Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 制造业
Company Introduction 公司是一家致力于结合人工合成材料特性，利用先进制造技术开发高性能植入医疗器械的高新技术企业。目前，公司是国内神经外科领域唯一同时拥有人工硬脑（脊）膜补片、颅颌面修补产品、可吸收止血纱等植入医疗器械产品的企业，覆盖开颅手术所需要的关键植入医疗器械。同时，公司以临床需求为导向，充分发挥多技术平台的优势，拓展产品至多科室的应用，致力于成为植入医疗器械领域全球领先企业，提供卓越的产品，服务于全球患者。 公司在国内率先利用生物增材制造技术开发出用于神经外科手术的可吸收硬脑（脊）膜补片，该产品是入选中国科技部《创新医疗器械产品目录（2018）》的唯一一款脑膜产品、也是目录中仅有的9项“国际原创”产品之一。为丰富神经外科产品线布局，公司拓展建立了数字化设计与精密加工、选择性氧化及微纤维网成型、多组分交联及雾化成胶等先进制造技术平台，成功开发出系列创新产品。其中，颅颌面修补产品是国内少数基于PEEK材料并用于颅颌面缺损修补的产品，已实现在国内外多个国家的销售；可吸收止血纱是专门针对神经外科手术止血需求所开发的高性能止血产品，目前已取得CE证书，正处于国内注册报批阶段，其产业化将有望打破我国神经外科可吸收止血产品的长期进口垄断；可吸收医用胶是国外神经外科手术中普遍使用的用于防止脑脊液渗漏的产品，目前该产品正处于临床试验阶段。同时，公司基于上述各技术平台进行跨科室的产品开发，逐步进入口腔科及其他外科领域。 经营范围：3D扫描及打印设备的研究开发；模具增材制造设备的研究开发；医学研究和试验发展；生物技术转让服务；生物技术开发服务；生物医疗技术研究；教学用模型及教具制造；生物技术咨询、交流服务；模型设计服务；医疗用品及器材零售(不含药品及医疗器械)；货物进出口(专营专控商品除外)；软件零售；软件服务；软件开发；材料科学研究、技术开发；其他合成材料制造(监控化学品、危险化学品除外)；模具增材制造设备的制造；模具增材制造设备的销售；增材制造及激光制造设备的销售；增材制造及激光制造设备的制造；增材制造及激光制造领域的技术推广和应用服务；非许可类医疗器械经营；劳务承揽；3D扫描及打印设备的制造；3D扫描及打印设备的销售；假肢、人工器官及植(介)入器械制造；许可类医疗器械经营
Main Business 结合人工合成材料特性，利用先进制造技术开发高性能植入医疗器械
Legal Representative 袁玉宇
Top Executives
董事长：袁玉宇
董事：骆雅红,王建华,龙小燕,郑海莹,袁美福
独立董事：颜光美,卢馨,陈晓峰
Top 5 Shareholder
Shareholder name Nature Holding Date
袁玉宇限售股+流通A股16.63%31/03/2024
徐弢限售股16.53%31/03/2024
深圳市凯盈科技有限公司流通A股6.43%31/03/2024
国寿成达（上海）健康产业股权投资中心（有限合伙）流通A股4.95%31/03/2024
袁美福限售股+流通A股4.40%31/03/2024
Company Secretary 龙小燕
Solicitors 北京市中伦律师事务所
Auditors 华兴会计师事务所（特殊普通合伙）
Tel No 020-32296118;020-32296113
Fax No 020-32296128
Website www.medprin.com
Email irm@medprin.com
Company Address
Register: 广东省广州高新技术产业开发区科学城揽月路80号E区第三层
Office: 广东省广州市黄埔区崖鹰石路3号
Listing Date 26/07/2021
Shares Capital
Shares Capital: 66,062,951
Total A Share: 66,062,951
Listed A Share: 37,551,070
Non-tradable A Share: 28,511,881
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 0.620
DPS(RMB)* ¥ 0.400
NBV Per Share(RMB)* ¥ 9.625
Market Capitalization(RMB) 1.483B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.